The Microbicide Trials Network brings together international investigators and community and industry partners whose work is focused on the rigorous evaluation of promising microbicides.
“A Look Back …” is an occasional series to honor the communities, researchers, staff and study participants who have made countless and meaningful contributions to the work of the MTN since 2006.
To keep updated on the impact of the COVID-19 pandemic on our studies, visit our COVID-19 Response page.
Studies at the Microbicide Trials Network are designed specifically to support the potential licensure and regulatory approval of HIV prevention products for populations most vulnerable to HIV.
The MTN partners with key civil society groups and other stakeholders to solicit their views on proposed studies and to discuss issues related to study implementation.
MTN is excited to share that the DELIVER study has completed enrollment of the first group of 150 participants.
Results of a sub-study of DELIVER called MTN-042B was published on March 31 in PLOS ONE.
The MTN-039 Phase I study of a fast-dissolving rectal insert for HIV prevention has completed follow-up.
Read "Finding the Silver Lining" - The latest installment in MTN's "A Look Back..." series.
Saying goodbye to Jared Baeten as MTN co-PI.
Check out the new "A Look Back..." page in our News area.
A leap forward for the dapivirine vaginal ring, the next steps are critical.
10,000-plus medical charts provides comparator for HIV prevention study in pregnant women
90-day dapivirine ring for women's HIV prevention passes its first test in Phase I study
One Size Doesn't Fit All When It Comes to Products for Preventing HIV from Anal Sex
Microbicide Trials Network